¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"dose response curve/relationship"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
¿µ¹® doctor-patient relationship ÇÑ±Û ÀÇ»çȯÀÚ°ü°è
¼³¸í   
  »çȸÀûÀ¸·Î ±â´ëµÇ´Â °¢ ¿ªÇÒ¿¡ µû¸¥ »óÈ£ÇàÀ§¸¦ ÅëÇØ¼­ ÀÇ»ç¿Í È¯ÀÚ°¡ ¸Î´Â °ü°è. ÀÇ»ç-ȯÀÚ°ü°è´Â, ¨ç ´Éµ¿Àû-¼öµ¿Àû°ü°è, ¨è Áöµµ-Çù·Â°ü°è, ¨é »óÈ£Âü°¡°ü°èÀÇ ¼¼ °¡Áö·Î À¯ÇüÈ­ÇÒ ¼ö ÀÖ´Ù. Áúº´±¸Á¶ÀÇ Áß½ÉÀÌ ±Þ¼º Áúȯ¿¡¼­ ¸¸¼ºÁúȯÀ¸·Î ÀÌÇàÇϴ °¡¿îµ¥ ÀÇ»ç-ȯÀÚ°ü°èµµ ¨ç¿¡¼­ ¨éÀ¸·Î ¹Ù²î´Â °ÍÀÌ ¿ä±¸µÇ°í ÀÖ´Ù. ±×·¯³ª ÀϹæÀûÀ¸·Î ÀÏÇϴ ÀÇ»ç¿Í Áö½Ã¿¡ µû¸£±â¸¸ Çϴ ¼öµ¿Àû È¯ÀÚ¿ÍÀÇ °ü°è´Â ¾ÆÁ÷µµ »Ñ¸®±í°Ô ³²¾ÆÀÖ´Ù. ¶Ç ÃÖ±ÙÀÇ ÀÇ·á±â°èÈ­´Â ÀÇ»ç¿Í È¯ÀÚ°¡ ±â°è¸¦ ¸Å°³·Î Çؼ­ °£Á¢ÀûÀ¸·Î »óÈ£¿¬°üµÇ´Â »õ·Î¿î °ü°è±îÁöµµ ³º°í ÀÖ´Ù.
¿µ¹® radiation dose ÇÑ±Û ¹æ»ç¼±·®
¼³¸í   
  ¹æ»ç¼±Á¶»çÀÇ Á¤µµ. ¹æ»ç¼±»ý¹°ÇÐÀ̳ª ÀÎüÀÇ ¹æ»ç¼±¹æÈ£¿¡¼­´Â Àü¸®¹æ»ç¼±ÀÇ ¾ç, Áï ¼±·®ÀÌ ¹®Á¦°¡ µÈ´Ù. ¹æ»ç¼±·®¿¡¼­µµ ±¹Á¦´ÜÀ§°è(SI)°¡ Ã¤¿ëµÇ¾î ±¹Á¦¹æ»ç¼±¹æÈ£À§¿øÈ¸(ICRP)ÀÇ ±Ç°í¿¡ µû¶ó¼­ ´ÙÀ½ÀÇ ¿©·¯ ´ÜÀ§°¡ ³Î¸® »ç¿ëµÈ´Ù. ¨ç Èí¼ö¼±·®(absorbed dose). ¹°ÁúÀÇ ´ÜÀ§Áú·®ÀÌ ¹æ»ç¼±¿¡ ÀÇÇØ ¹Þ¾ÆµéÀ̴ ¿¡³ÊÁö. ÀÌ ´ÜÀ§´Â ¹æ»ç¼± ¹× ¹°ÁúÀÇ Á¾·ù°¡ ¾î¶°ÇÑ °ÍÀÌ´õ¶óµµ »ç¿ëÇÒ ¼ö ÀÖ´Ù. ±¹Á¦´ÜÀ§´Â J/kgÀ̸ç À̰Ϳ¡ °íÀ¯ÇÑ ¸íĪÀ¸·Î ±×·¹ÀÌ(gray, ±âÈ£ Gy)°¡ ºÎ¿©µÈ´Ù. 1Gy=100¶óµå(rad). ¨è Á¶»ç¼±·®(exposure) ¶Ç´Â °øÁß¼±·®. X¼± ¶Ç´Â ¥ã¼±¿¡ ÇÑÇØ¼­ »ç¿ëµÈ´Ù. ±¹Á¦´ÜÀ§´Â C/kg. ¨é ¼±·®´ç·®(dose equivalent). ¹æ»ç¼±¹æÈ£¸¦ À§ÇØ »ç¿ëµÇ´Â ¾ç. ±âÈ£´Â H. H´Â ¹æ»ç¼±ÀÇ Á¾·ù¿Í ¿¡³ÊÁö¿¡ ÀÇÇØ »ýü¿¡ Áִ ȿ°ú¸¦ º¸Á¤Çϴ ¼±Áú°è¼ö(Q)¿Í ±× ¹ÛÀÇ ÀÎÀÚ(¿¹¸¦ µé¸é ¼±·®·ü, ¹æ»ç¼ºµ¿À§¿ø¼Ò¿¡ ÀÇÇÑ ³»ºÎÇÇÆø½Ã¿¡´Â ±× ÇÙÁ¾ÀǠü³»ºÐÆ÷ µî)¿¡ ±Ù°ÅÇÑ º¸Á¤°è¼ö(N)¸¦ Èí¼ö¼±·®(D)¿¡ °öÇÑ °Í, Áï H=D-Q-N. ¶ÇÇÑ DÀÇ ´ÜÀ§¸¦ Gy ¶Ç´Â rad·Î Ç¥½ÃÇÏ¿´À» ¶§ HÀÇ ´ÜÀ§¸¦ °¢°¢ ½Ãº£¸£Æ®(sievert, ±âÈ£ Sv) ¹× ·½(rem)À̶ó°í ÇÑ´Ù. µû¶ó¼­ 1 Sv=102rem. ÀϹÝÀûÀ¸·Î ´ÜÀ§½Ã°£´çÀÇ ¼±·®À» ¼±·®·ü(dose rate)À̶ó°í ÇÑ´Ù.
¿µ¹® dose ÇÑ±Û ¿ë·®, Åõ¿©·®, ¹æ»ç¼±·®
¼³¸í   
  1. ¾àÁ¦¸¦ ÇÑ ¹ø ¶Ç´Â ÇÏ·ç¿¡ »ç¿ëÇϰųª º¹¿ëÇϴ ºÐ·®. 2. ¹°ÁúÀ̳ª Á¶Á÷¿¡ ´ëÇÑ ¹æ»ç¼±ÀÇ ÀÛ¿ë Á¤µµ¸¦ ³ªÅ¸³»´Â ¾ç. Áï, ¹æ»ç¼±·®À̶ó´Â °³³äÀº ¾î¶² ÇÑ Á¡¿¡ ÀÔ»çÇϴ ¹æ»ç¼±°ú ±× Á¡ ±Ùó¿¡ Àִ ¹°Áú¿¡ ´ëÇÑ ¹æ»ç¼±ÀÇ ¹°¸®Àû-È­ÇÐÀû-»ý¹°ÇÐÀû È¿°ú¿ÍÀÇ °ü°Ô¸¦ Á¤·®ÀûÀ¸·Î ³ªÅ¸³»´Â °øÅëÀΠôµµ·Î¼­ »ý°¢µÈ °ÍÀÌ´Ù. ¶óµå(rad)·Î ³ªÅ¸³»´Â Èí¼ö·®, ·»Æ®°Õ(R)À¸·Î ³ªÅ¸³»´Â Á¶»ç ¼±·®, ·½(rem)À¸·Î ³ªÅ¸³»´Â ¼±·® ´ç·®À¸·Î ±¸ºÐÇÏ¿© ¾´´Ù.
¿µ¹® skin dose ÇÑ±Û ÇǺμ±·®
¼³¸í   
  1. ÇǺÎÇ¥¸é¿¡¼­ÀÇ ¹æ»ç¼±ÀÇ °øÁß¼±·®À¸·Î ¿©±â¿¡´Â 1Â÷¹æ»ç¼±°ú ÈĹæ»ê¶õÀÌ Æ÷ÇԵȴÙ. 2. ÇǺο¡ Èí¼öµÇ´Â ¼±·®.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • dose-response relationship
    ¿ë·®¹ÝÀÀ°ü°è
  • dose-response curve
    ¿ë·®¹ÝÀÀ°î¼±
  • sigmoid dose-response curve
    ±¸ºÒ¼±·®¹ÝÀÀ°î¼±
  • concentration-response curve
    ³óµµ¹ÝÀÀ°î¼±
  • frequency response curve
    Á֯ļö¹ÝÀÀ°î¼±
  • response curve
    ¹ÝÀÀ°î¼±
  • depth dose curve
    ½ÉºÎ¼±·®°î¼±
  • percentage depth dose curve
    ½ÉºÎ¼±·®¹éºÐÀ²°î¼±
  • causal relationship
    Àΰú°ü°è
  • child-parent relationship
    ¾î¸°À̺θð°ü°è
  • doctor-patient relationship
    ÀÇ»çȯÀÚ°ü°è
  • relationship
    °ü°è
  • structure activity relationship
    ±¸Á¶È°¼º»ó°ü°ü°è, ±¸Á¶ÀÛ¿ë°ü°è
  • symbiotic relationship
    °ø»ý°ü°è
  • working relationship
    ÀÛ¾÷°ü°è
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • dose-response relationship
    ¿ë·®¹ÝÀÀ°ü°è
  • response curve
    ¹ÝÀÀ°î¼±
  • relationship
    °ü°è
  • doctor-patient relationship
    ÀÇ»çȯÀÚ°ü°è
  • curve
    °î¼±
  • epidemic curve
    À¯Çà°î¼±
  • learning curve
    ÇнÀ°î¼±
  • regression curve
    ȸ±Í°î¼±
  • survival curve
    »ýÁ¸°î¼±
  • response decline
    ¹ÝÀÀ°¨¼Ò
  • response
    ¹ÝÀÀ
  • autoimmune response
    ÀÚ°¡¸é¿ª¹ÝÀÀ
  • inflammatory response
    ¿°Áõ¹ÝÀÀ
  • late asthmatic response
    ¸¸±âõ½Ä¹ÝÀÀ, Èıâõ½Ä¹ÝÀÀ
  • response rate
    ¹ÝÀÀ·ü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • dose response relationship
    ¿ë·®¹ÝÀÀ°ü°è
  • dose-response curve
    ¿ë·®¹ÝÀÀ°î¼±
  • sigmoid dose-response curve
    ±¸ºÒ¼±·®¹ÝÀÀ°î¼±
  • time dose relationship
    ½Ã°£¿ë·®°ü°è
  • concentration-response curve
    ³óµµ¹ÝÀÀ°î¼±
  • frenquency response curve
    Á֯ļö¹ÝÀÀ°î¼±
  • response curve
    ¹ÝÀÀ°î¼±
  • depth dose curve
    ½ÉºÎ¼±·®°î¼±
  • percentage depth dose curve
    ½ÉºÎ¼±·®¹éºÐÀ²°î¼±
  • causal relationship
    Àΰú°ü°è
  • child-parent relationship
    ¾î¸°À̺θð°ü°è
  • doctor-patient relationship
    ÀÇ»çȯÀÚ°ü°è
  • host-parasite relationship
    ¼÷ÁÖ±â»ýü»óÈ£°ü°è
  • relationship
    °ü°è
  • structure activity relationship
    ±¸Á¶È°¼º»ó°ü°ü°è, ±¸Á¶ÀÛ¿ë°ü°è
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • frenquency response curve
    Á֯ļö ¹ÝÀÀ°î¼±
  • Larmor relationship
    ¶ó¸ð °ü°è
  • SAR : structure activity relationship
    ±¸Á¶ÀÛ¿ë°ü°è.
  • AUC : area under the concentration-time curve
    Ç÷Áß(¾à¹°)³óµµ°î¼±ÇϸéÀû.
  • Hemoglobin-oxygen equilibrium curve
    Çì¸ð±Û·Îºó-»ê¼Ò°î¼±
  • Length/tension curve
    ±æÀÌ/Àå·Â(íåÕô) °î¼±(ÍØàÊ)
  • area under the concentration-time curve : AUC
    Ç÷Áß(¾à¹°)³óµµ°î¼±ÇϸéÀû.
  • frequency curve
    µµ¼ö°î¼±(̬ËàË­ËÛ).
  • frequency curve
    µµ¼ö°î¼±
  • frequency distribution curve
    µµ¼öºÐÆ÷°î¼±.
  • frequency distribution curve
    µµ¼öºÐÆ÷°î¼±
  • glow curve
    ¹é¿­°î¼±
  • growth curve
    Áõ½Ä°î¼±, ¼ºÀå°î¼±.
  • growth curve
    Áõ½Ä°î¼±
  • growth curve, one-step
    ÀÏȸÁõ½Ä°î¼±
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • dose response curve/relationship
    ¿ë·®-¹ÝÀÀ°î¼±/°ü°è.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • dose response relationship
    ¹æ»ç ¾à¸®,»ý¸®,»ýÈ­,ÇÙÀǿ뷮¹ÝÀÀ°ü°è (¡­Î¼Ìõ).
  • dose-response relationship
    ¼±·®¹ÝÀÀ°ü°è
  • dose response curve
    ¹æ»ç [¾à¸®,º´¸®,»ýÈ­,ÇÙÀÇ]¿ë·®¹ÝÀÀ°î¼±(éÄåÖÚãëëÍØàÊ).
  • dose response curve
    ¹æ»ç ¾à¸®,º´¸®,»ýÈ­,ÇÙÀǿ뷮´ëÀÀ°î¼±(éÄåÖÓßëëÍØàÊ).
  • dose-response curve
    ¼±·®¹ÝÀÀ°î¼±
  • dose-response curve
    ¿ë·®¹ÝÀÀ°î¼±(éÄÕáÚãëëÍØàÊ)
  • dose-effect relationship
    ¼±·®¿µÇâ°ü°è
  • time dose relationship
    ½Ã°£¿ë·®°ü°è.
  • concentration-response curve
    ³óµµ¹ÝÀÀ°î¼±
  • frenquency response curve
    Á֯ļö ¹ÝÀÀ°î¼±
  • response curve
    ¹ÝÀÀ°î¼±
  • sigmoid dose-response curves
    ½Ã±×¸ðÀÌµå ¼±·®¹ÝÀÀ°î¼±, S ÀÚÇü-
  • depth dose curve
    ½ÉºÎ¼±·®°î¼±
  • percentage depth dose curve
    ½ÉºÎ¼±·®¹éºÐÀ²°î¼±
  • cumulative dose ; cumulate dose
    ´©Àû¿ë·®.
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • host parasite relationship
    ¼÷ÁÖ±â»ýÃæ°ü°è
  • symbiotic relationship
    °ø¼­»ýȰ°ü°è
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • dose-response curve
    ¿ë·®´ëÀÀ °î¼±(é»ÕáÓßëëÍØàÊ)
  • adaptive response
    ÀûÀÀÀû ´ëÀÀ(îêëëîÜÓßëë)
  • anamnestic response
    ÀÌÂ÷¸é¿ª¹ÝÀÀ(ì£ó­Øóæ¹Úãëë)
  • anaphylactic response
    ¾Æ³ªÇʶô½Ã½º ´ëÀÀ(Óßëë)
  • antibody response
    Ç×ü ´ëÀÀ(ù÷ô÷Óßëë)
  • autoimmune response
    ÀÚ°¡¸é¿ª´ëÀÀ (í»Ê«Øóæ¹Óßëë)
  • biological response modifier
    »ý¹°ÇÐÀû ´ëÀÀ¼ö½ÄÀÚ(ßæÚªùÊîÜÓßëëáóãÞí­)
  • booster response
    ºÎ½ºÅÍ ´ëÀÀ(Óßëë)
  • heat shock response
    ¿­(æð)
  • immune response
    ¸é¿ª ´ëÀÀ(Øóæ¹Óßëë)
  • immune response gene
    ¸é¿ª ´ëÀÀ À¯ÀüÀÚ(Øóæ¹Óßëëë¶îîí­)
  • lysogenic response
    ¿ë¿ø´ëÀÀ(éÁê«Óßëë)
  • lytic response
    ¿ëÇØ´ëÀÀ(éÁú°Óßëë)
  • memory response
    ±â¾ï´ëÀÀ(ÑÀåãÓßëë)
  • phosphatidylinositol response
    Æ÷½ºÆÄƼµô ´ëÀÀ(Óßëë)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Larmor relationship
    ¶ó¸ð °ü°è
  • response
    ¹ÝÀÀ, ÀÀ´äÀÇ
  • response frequency
    ¹ÝÀÀÁ֯ļö
  • curve
    °î¼±
  • dissociation curve
    ÇØ¸®°î¼±
  • elastic curve
    ź¼º°î¼±
  • exponential curve
    Áö¼ö°î¼±
  • fluid velocity curve
    À¯¼Ó°î¼±
  • growth curve
    Áõ½Ä°î¼±, ¼ºÀå°î¼±
  • isodose curve
    µî¼±·®°î¼±
  • phase curve
    À§»ó°î¼±
  • time compensation curve
    ½Ã°£º¸»ó°î¼±
  • time gain compenstaion curve
    ½Ã°£°ÔÀκ¸»ó°î¼±
  • time motion curve
    ½Ã°£¿îµ¿°î¼±
  • air dose
    °øÁß¼±·®, °ø±âÁß¼±·®
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ECG Electro-Cardio-Graphy(-Gram); ½ÉÀüµµ
   = EKG
  1. Conducting System Structu...
ID identification; iditol dehydrogenase; immunodeficiency; immunodiffusion; immunoglobulin deficiency; ...
AER abduction/external rotation; acoustic evoked response; acute exertional rhabdomyolysis; agranular en...
SR sarcoplasmic reticulum; saturation recovery; scanning radiometer; screen; secretion rate; sedimentat...
FTC Federal Trade Commission; follicular thyroid carcinoma; frequency threshold curve; frequency tuning ...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
AUC Area-under-the-response-curve
CRC concentration response curve
PRC Phase response curve
CCRT Core Conflictual Relationship Theme
ESPVR End-systolic pressure-volume relationship
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • dose response relationship
    ¹æ»ç¿ë·® ¹ÝÀÀ °ü°è, ¿ë·® ¹ÝÀÀ °ü°è
  • dose-response curve
    ¿ë·® ¹ÝÀÀ °î¼±
  • dose-effect relationship
    ¼±·® ¿µÇâ °ü°è
  • concentration-response curve
    ³óµµ ¹ÝÀÀ °î¼±
  • causal relationship
    Àΰú °ü°è
  • doctor-patient relationship
    ÀÇ»ç-ȯÀÚ °ü°è, ÀÇ»ç ȯÀÚ ½Å·Ú °ü°è
  • end to end relationship
    Àý´Ü¸é°ú Àý´Ü¸é °ü°è
  • host-parasitite relationship
    ¼÷ÁÖ-±â»ýüÀÇ »óÈ£ °ü°è
  • intercuspal position relationship
    ±³µÎ°£À§ °ü°è
  • interpersonal relationship
    ´ëÀÎ °ü°è
  • jawcranial base relationship
    ¾Ç°ñ µÎ°³ÀúÀÇ °ü°è
  • maladaptive biomechanical relationship
    ºñÀûÀÀ¼º »ý¿ªÇÐÀû °ü°è
  • maxillomandibular relationship
    »óÇÏ¾Ç °ü°è
  • open occlusal relationship
    °³±¸ ±³ÇÕ °ü°è
    ±³ÇÕÇÏ´Â À§Ä¡¿¡¼­ Ä¡¾Æ Á¢ÃËÀÇ °á¿©.
  • posterior open occlusal relationship
    ±¸Ä¡ À̰³ ±³ÇÕ °ü°è
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
dose-response relationship Relationship in which a change in the amount, intensity, or duration of exposure is associated with a change in risk of a specified outcome.
(05 Mar 2000)
dose-response relationship, drug The relationship between the dose of an administered drug and the response of the organism to the drug.
(12 Dec 1998)
dose-response relationship, immunologic A specific immune response elicited by a specific dose of an immunologically active substance or cell in an organism, tissue, or cell.
(12 Dec 1998)
dose-response relationship, radiation The relationship between the dose of administered radiation and the response of the organism or tissue to the radiation.
(12 Dec 1998)
dose-response curve This is a graph to show the relation between the dose of a drug or other chemical and the degree of response it produces, as measured by the percentage of the exposed population showing a defined, often quantal, effect.
(09 Oct 1997)
dose-effect curve This is a graph drawn to show the relationship between the dose of a drug or other chemical and the magnitude of the graded effect that it produces.
(09 Oct 1997)
concentration-response curve <pharmacology> This is a graph produced to show the relation between the exposure concentration of a drug (or other chemical) and the degree of response it produces, as measured by the percentage of the exposed population showing a defined, often quantal, effect.
(05 Jan 1998)
blood relationship A relationship that share a common bloodline, descent from a common ancestor.
(27 Sep 1997)
relationship The state of being related, associated, or connected.
(05 Mar 2000)
coefficient of relationship The probability that a gene present in one mate is also present in the other and is derived from the same source.
(05 Mar 2000)
Haldane relationship <biochemistry> A mathematical relationship between the equilibrium constant of an enzyme-catalyzed reaction and all of that enzyme's kinetic parameters (e.g., Vmax and Km's).
(05 Mar 2000)
sadomasochistic relationship A relationship characterised by the complementary enjoyment of inflicting and suffering cruelty.
(05 Mar 2000)
hypnotic relationship Relationship between hypnotiser, or hypnotist, and the hypnotised, or hypnotee.
(05 Mar 2000)
structure-activity relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Other factors contributing to structure-activity relationship include chemical reactivity, electronic effects, resonance, and inductive effects.
(12 Dec 1998)
object relationship In the behavioural sciences, the emotional bond between an individual and another person (or between two groups), as opposed to the individual's (or group's) interest in him or herself (itself).
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • response curve
    (¸¶ÀÌÅ©·ÎÆùµîÀÇ)ÀÀ´ä °î¼±
  • relationship
    Ä£Á·°ü°è
  • relationship
    °ü°è;ģô°ü°è 
  • dose
    ¾àÀÇ 1ȸºÐ;~¿¡ Åõ¾àÇÏ´Ù;º¹¿ë½ÃŰ´Ù
  • maximum dose
    (¾àÀÇ) ±Ø·®
  • minimum dose
    ÃÖ¼Ò Åõ¾à·®
  • curve
    ±¸ºÎ¸®´Ù
  • French curve
    ¿îÇüÀÚ
  • characteristic curve
    Ư¼º °î¼±
  • curve
    °î¼±;(¿©ÀÚÀÇ ¸ö.µµ·Î µîÀÇ)¸¸°îºÎ;±¼°î;(¿©ÀÚÀÇ)°î¼±¹Ì;±¸ºÎ··ÀÌ;°î¼±ÀÚ;°î¼± µµÇ¥;±×·¡ÇÁ;°î¼±;Ä¿ºê(°ø);Ä¿ºê Æò°¡;»ó´ë Æò°¡;±ÁÈ÷´Ù;¸¸°î½ÃŰ´Ù;(°øÀ»)Ä¿ºê½ÃŰ´Ù;±¸ºÎ·¯Áö´Ù;¸¸°îÇÏ´Ù;°î¼±À» ±×¸®´Ù
  • curve killer
    ¿ìµî»ý
  • distribution curve
    (Åë°è)ºÐÆ÷ °î¼±
  • hanging curve
    Çà°Å Ä¿ºê(±¸ºÎ·¯ÁöÁö ¾ÊÀº Ä¿ºê·Î,¶§¸®±â ÁÁÀº °øÀÌ µÊ)
  • howgozit curve
    (ƯÈ÷ ´ë¾çȾ´Ü Ç×°øÁßÀÇ)»óȲ ÆÇ´Ü °î¼±
  • indifference curve
    (°æ) ¹«Â÷º°°î¼±
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á